PHASQ / PhaseBio Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

PhaseBio Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US7172241090
ACEST SIMBOL NU MAI ESTE ACTIV

Acțiuni Insider12.488.536 shares
Scorul de sentimente din interior

Insider Sentiment Score găsește companiile cumpărate de persoane din interior.

Este rezultatul unui model cantitativ sofisticat, multifactorial, care identifică companiile cu cele mai înalte niveluri de acumulare de persoane interne. Modelul de scoring folosește o combinație a numărului net de persoane din interior care cumpără în ultimele 90 de zile, totalul acțiunilor cumpărate ca procent din flota și totalul acțiunilor deținute de insider. Numărul variază de la 0 la 100, numerele mai mari indicând un nivel mai ridicat de acumulare pentru semenii săi, iar 50 fiind media.

Frecvența actualizării: zilnic

Vedeți Top Picks Insiders, care oferă o listă a companiilor cu cea mai mare acumulare de persoane din interior.

Scorul de sentiment al ofițerului

Scorul de sentiment al ofițerilor găsește companii cumpărate de ofițerii corporativi.

Prin definiție, Ofițerii Corporativi sunt Corporate Insiders, dar spre deosebire de unii dintre ceilalți Insiders (10% Acționari și Membri ai Consiliului de Administrație), Ofițerii lucrează zilnic pentru companie și își folosesc banii atunci când tranzacționează . (10% acționari și membri ai consiliului de administrație sunt adesea administratori de fonduri care gestionează banii altor persoane.) Ca atare, tranzacțiile privilegiate efectuate de către ofițeri sunt mult mai semnificative și ar trebui tratate în mod corespunzător.

La fel ca Scorul Sentimentului Insider, Scorul Sentimentului Ofițerului este rezultatul unui model cantitativ sofisticat, multifactorial, care identifică companiile cu cele mai înalte niveluri de acumulare de ofițeri.

Frecvența actualizării: zilnic

Vedeți Top Picks Insiders, care oferă o listă a companiilor cu cel mai mare sentiment din interior.

Valori cheie ale insiderului

Acest card arată modul în care compania se clasifică de-a lungul diferitelor valori interne. Clasamentul percentilei arată cum se compară această companie cu alte companii de pe piețele din SUA. Clasamentele mai înalte indică situații mai bune.

De exemplu, este în general acceptat că cumpărarea din interior este un indicator pozitiv, astfel încât companiile cu mai multe achiziții din interior s-ar clasa mai sus decât companiile cu mai puține achiziții din interior (sau chiar vânzări din interior).

Numărul net de persoane din interior care cumpără (clasament)

N/A

Numărul net de persoane din interior care cumpără este numărul total de persoane din interior care cumpără minus numărul total de persoane din interior care au vândut în ultimele 90 de zile. Rangul percentilei este afișat aici (interval de la 0 la 100%).

Procent din flota cumpărată de persoane din interior (clasament)

N/A

Procent of Float Bought by Insiders este numărul total de acțiuni cumpărate de insiders minus numărul total de acțiuni vândute de insiders în ultimele 90 de zile, împărțit la flota totală și înmulțit cu 100.

Graficul privind tranzacțiile privilegiate

PhaseBio Pharmaceuticals, Inc. tranzacții privilegiate sunt prezentate în graficul următor. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. În general, este în general ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații materiale, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4.

Lista de persoane din interior și valori de profitabilitate

Acest tabel prezintă lista persoanelor din interior cunoscute și este generată automat din dosarele dezvăluite SEC. Pe lângă nume, cel mai recent titlu și desemnarea directorului, a ofițerului sau a proprietarului în proporție de 10%, oferim cele mai recente dețineri divulgate. În plus, atunci când este posibil, oferim performanța comercială istorică pentru persoane din interior. Performanța comercială istorică este o medie ponderată a performanței tranzacțiilor reale de cumpărare pe piață deschisă efectuate de către insider. Pentru mai multe informații despre cum se calculează, urmăriți acest webinar YouTube.

See our leaderboard of most profitable insider traders.

Insider Profit mediu (%) Acțiuni
Deținut
Despică
Ajustat

Report errors via our new Insider Auditing Tool

Înregistrări ale achizițiilor interne - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în PHASQ / PhaseBio Pharmaceuticals, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție și rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
2021-08-18 Thorp Clay 10.000 3,0000 10.000 3,0000 30.000 76 4.05 10.500 35,00
2021-08-18 Hutson Nancy J 3.000 3,0800 3.000 3,0800 9.240
2020-12-03 HARRIGAN EDMUND 6.000 4,1200 6.000 4,1200 24.720
2020-11-24 Thorp Clay 2.000 3,5000 2.000 3,5000 7.000
2020-11-23 Thorp Clay 3.000 3,6700 3.000 3,6700 11.010
2018-12-17 Hutson Nancy J 1.000 4,4600 1.000 4,4600 4.460
2018-12-13 Ballance David James 1.000 3,9400 1.000 3,9400 3.940
2018-12-13 Mow Jonathan P 1.000 3,6900 1.000 3,6900 3.690
2018-12-11 York Michael 1.500 3,8800 1.500 3,8800 5.820

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate reprezintă acțiunile ajustate în funcție de divizarea.

PHASQ / PhaseBio Pharmaceuticals, Inc. Insider Trades
Înregistrări ale vânzărilor din interior - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în PHASQ / PhaseBio Pharmaceuticals, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție și rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
2022-10-25 NEW ENTERPRISE ASSOCIATES 13 LP 1.784.109 0,1470 1.784.109 0,1470 262.264 8 0.0701 -137.198 -52,31
2021-05-20 Burkhardt Glen 3.811 3,2900 3.811 3,2900 12.538
2020-11-23 Burkhardt Glen 3.497 3,4500 3.497 3,4500 12.065

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate reprezintă acțiunile ajustate în funcție de divizarea.

PHASQ / PhaseBio Pharmaceuticals, Inc. Insider Trades
Istoricul tranzactiilor

Faceți clic pe pictograma link pentru a vedea istoricul complet al tranzacțiilor. Tranzacțiile raportate ca parte a unui plan de tranzacționare automată 10b5-1 vor avea un X în coloana marcată 10b-5.

Fişier
Data
Comerț
Data
Formă Insider Ticker Titlul de securitate Cod 10b5-1 Direct Exercițiu
Preț
Unitate
Preț
Unități
Schimbat
Valoare
Schimbat (1K)
Rămas
Opțiuni
Rămas
Acțiuni
2023-05-19 2023-05-19 4 Humphries William D. PHAS Common Stock M - Exercise D 2.538 2.538
2023-05-19 2023-05-19 4 Thorp Clay PHAS Common Stock M - Exercise D 3.750 36.693
2023-05-19 2023-05-19 4 van den Broek Richard PHAS Common Stock A - Award D 3.750 0
2023-05-19 2023-05-19 4 Loewy Caroline M PHAS Common Stock M - Exercise D 3.750 3.750
2023-05-19 2023-05-19 4 Sapir Alex PHAS Common Stock M - Exercise D 3.750 3.750
2023-05-19 2023-05-19 4 HARRIGAN EDMUND PHAS Common Stock M - Exercise D 3.750 9.750
2023-05-19 2023-05-19 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3.750 37.510
2022-10-26 2022-10-25 4 NEW ENTERPRISE ASSOCIATES 13 LP PHAS Common Stock S - Sale D 0,1470 -1.784.109 -262 4.857.525
2022-05-24 2022-05-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 0,6813 10.917 7 41.236
2022-05-24 2022-05-20 4 Mow Jonathan P PHAS Common Stock A - Award D 0,6813 10.918 7 132.502
2022-05-24 2022-05-20 4 Hanson Kristopher PHAS Common Stock A - Award D 0,6813 4.831 3 8.463
2022-05-24 2022-05-20 4 Birchall Jonathan PHAS Common Stock A - Award D 0,6813 20.000 14 20.000
2022-05-24 2022-05-23 4 Burkhardt Glen PHAS Common Stock S - Sale D 0,7900 -11.248 -9 0
2022-05-24 2022-05-20 4 Burkhardt Glen PHAS Common Stock A - Award D 0,6813 11.248 8 11.248
2022-05-24 2022-05-20 4 Sharp John P PHAS Common Stock A - Award D 0,6813 6.026 4 65.767
2022-05-20 2021-08-18 4/A Hutson Nancy J Held in an individual retirement account for the benefit of the Reporting Person PHAS Common Stock P - Purchase I 3,0800 3.000 9 4.000
2022-05-20 2022-05-19 4 Thorp Clay PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 Humphries William D. PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 Humphries William D. PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 Loewy Caroline M PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 Sapir Alex PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 Hutson Nancy J PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 van den Broek Richard PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-05-20 2022-05-19 4 HARRIGAN EDMUND PHAS Restricted Stock Units A - Award D 3.750 3.750
2022-05-20 2022-05-19 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,84 17.500 17.500
2022-02-28 2022-02-24 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 1,13 87.500 87.500
2022-02-28 2022-02-24 4 Burkhardt Glen PHAS Restricted Stock Unit A - Award D 18.750 18.750
2022-02-28 2022-02-24 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 1,13 115.500 115.500
2022-02-28 2022-02-24 4 Sharp John P PHAS Restricted Stock Unit A - Award D 24.750 24.750
2022-02-28 2022-02-24 4 Birchall Jonathan PHAS Employee Stock Option (right to buy) A - Award D 1,13 52.500 52.500
2022-02-28 2022-02-24 4 Birchall Jonathan PHAS Restricted Stock Unit A - Award D 11.250 11.250
2022-02-28 2022-02-24 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 1,13 87.500 87.500
2022-02-28 2022-02-24 4 Arnold Susan Elizabeth PHAS Restricted Stock Unit A - Award D 18.750 18.750
2022-02-28 2022-02-24 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 1,13 115.500 115.500
2022-02-28 2022-02-24 4 Lee John Sang PHAS Restricted Stock Unit A - Award D 24.750 24.750
2022-02-28 2022-02-24 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 1,13 385.000 385.000
2022-02-28 2022-02-24 4 Mow Jonathan P PHAS Restricted Stock Unit A - Award D 82.500 82.500
2022-02-28 2022-02-24 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 1,13 87.500 87.500
2022-02-28 2022-02-24 4 Hanson Kristopher PHAS Restricted Stock Unit A - Award D 18.750 18.750
2021-11-23 2021-11-19 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 2,0100 2.559 5 30.319
2021-11-23 2021-11-19 4 Mow Jonathan P PHAS Common Stock A - Award D 2,0100 5.623 11 172.473
2021-11-23 2021-11-19 4 Sharp John P PHAS Common Stock A - Award D 2,0100 2.017 4 59.741
2021-11-23 2021-11-19 4 Hanson Kristopher PHAS Common Stock A - Award D 2,0100 1.545 3 3.632
2021-11-23 2021-11-19 4 Burkhardt Glen PHAS Common Stock S - Sale D 2,3700 -5.766 -14 0
2021-11-23 2021-11-19 4 Burkhardt Glen PHAS Common Stock A - Award D 2,0100 5.766 12 5.766
2021-11-09 2021-11-08 4 Birchall Jonathan PHAS Employee Stock Option (right to buy) A - Award D 3,37 3,3700 250.000 842 250.000
2021-11-08 2021-11-08 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 3,15 3,1500 -7.400 -23 0
2021-11-08 2021-11-08 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3,1500 7.400 23 33.760
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 3,15 3,1500 -1.500 -5 7.400
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 2,26 2,2600 -24.860 -56 2.256
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3,1500 1.500 5 26.360
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Common Stock M - Exercise D 2,2600 24.860 56 24.860
2021-11-03 2021-11-03 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,68 1,6800 -7.500 -13 90.582
2021-11-03 2021-11-03 4 Sharp John P PHAS Common Stock M - Exercise D 1,6800 7.500 13 57.724
2021-11-03 2021-11-03 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 1,2400 -20.000 -25 108.767
2021-11-03 2021-11-03 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 20.000 25 166.850
2021-09-15 2021-09-14 4 Humphries William D. PHAS Non-employee Director Stock Option (right to buy) A - Award D 2,80 28.000 28.000
2021-09-03 2021-07-12 4/A Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1,74 -4.519 0
2021-09-03 2021-07-12 4/A Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1,7400 4.519 8 27.760
2021-09-03 2021-08-03 4/A Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,68 -7.500 98.082
2021-09-03 2021-08-03 4/A Sharp John P PHAS Common Stock M - Exercise D 1,6800 7.500 13 50.224
2021-08-30 2021-08-27 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 -20.000 128.767
2021-08-30 2021-08-27 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 20.000 25 146.850
2021-08-19 2021-08-18 4 Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person PHAS Common Stock P - Purchase I 3,0800 3.000 9 4.000
2021-08-18 2021-08-18 4 Thorp Clay PHAS Common Stock P - Purchase D 3,0000 10.000 30 32.943
2021-08-04 2021-08-03 4 Sharp John P PHAS Common Stock A - Award D 1,6800 7.500 13 50.224
2021-07-14 2021-07-12 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 1,7400 4.519 8 27.760
2021-06-04 2021-06-03 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-06-04 2021-06-03 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,53 14.000 14.000
2021-05-24 2021-05-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 2,8000 5.257 15 23.241
2021-05-24 2021-05-20 4 York Michael PHAS Common Stock A - Award D 2,8000 2.897 8 7.059
2021-05-24 2021-05-20 4 Hanson Kristopher PHAS Common Stock A - Award D 2,8000 1.088 3 2.087
2021-05-24 2021-05-20 4 Mow Jonathan P PHAS Common Stock A - Award D 2,8000 3.964 11 126.850
2021-05-24 2021-05-20 4 Burkhardt Glen PHAS Common Stock S - Sale D 3,2900 -3.811 -13 0
2021-05-24 2021-05-20 4 Burkhardt Glen PHAS Common Stock A - Award D 2,8000 3.811 11 3.811
2021-05-24 2021-05-20 4 Sharp John P PHAS Common Stock A - Award D 2,8000 1.419 4 42.724
2021-02-09 2021-02-05 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 4,31 234.000 234.000
2021-02-09 2021-02-05 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 4,31 36.000 36.000
2021-02-09 2021-02-05 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 4,31 36.000 36.000
2021-02-09 2021-02-05 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 4,31 36.000 36.000
2021-02-09 2021-02-05 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 4,31 76.500 76.500
2021-02-09 2021-02-05 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 4,31 76.500 76.500
2021-02-09 2021-02-05 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 4,31 36.000 36.000
2020-12-04 2020-12-03 4 HARRIGAN EDMUND PHAS Common Stock P - Purchase D 4,1200 6.000 25 6.000
2020-11-24 2020-11-24 4 Thorp Clay PHAS Common Stock P - Purchase D 3,5000 2.000 7 22.943
2020-11-24 2020-11-23 4 Thorp Clay PHAS Common Stock P - Purchase D 3,6700 3.000 11 20.943
2020-11-23 2020-11-20 4 Sharp John P PHAS Common Stock A - Award D 3,0000 1.305 4 41.305
2020-11-23 2020-11-20 4 Hanson Kristopher PHAS Common Stock A - Award D 3,0000 999 3 999
2020-11-23 2020-11-20 4 York Michael PHAS Common Stock A - Award D 3,0000 2.662 8 4.162
2020-11-23 2020-11-20 4 Ballance David James PHAS Common Stock A - Award D 3,0000 919 3 8.519
2020-11-23 2020-11-20 4 Mow Jonathan P PHAS Common Stock A - Award D 3,0000 3.643 11 122.886
2020-11-23 2020-11-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 3,0000 4.832 14 17.984
2020-11-23 2020-11-23 4 Burkhardt Glen PHAS Common Stock S - Sale D 3,4500 -3.497 -12 0
2020-11-23 2020-11-20 4 Burkhardt Glen PHAS Common Stock A - Award D 3,0000 3.497 10 3.497
2020-11-18 2020-11-16 4 Thorp Clay By Catalysta Ventures, LLC PHAS Common Stock J - Other I 10.586 15.432
2020-11-18 2020-11-16 4 Thorp Clay PHAS Common Stock J - Other D 2.144 17.943
2020-11-18 2020-11-16 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock J - Other I -52.397 0
2020-10-05 2020-10-01 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1,15 1,1500 -5.423 -6 0
2020-10-05 2020-10-01 4 Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1,1500 5.423 6 13.152
2020-10-05 2020-02-27 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1,15 1,1500 -5.423 -6 0
2020-10-05 2020-02-27 4 Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1,1500 5.423 6 7.729
2020-08-24 2020-08-21 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 -10.000 148.767
2020-08-24 2020-08-21 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 10.000 12 119.243
2020-08-17 2020-08-14 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,69 -5.000 105.582
2020-08-17 2020-08-14 4 Sharp John P PHAS Common Stock M - Exercise D 1,6900 5.000 8 40.000
2020-06-05 2020-06-03 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 4.909 4.909
2020-06-05 2020-06-03 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 0,00 16.000 16.000
2020-06-05 2020-06-03 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16.000 16.000
2020-06-05 2020-06-03 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16.000 16.000
2020-06-05 2020-06-03 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16.000 16.000
2020-06-05 2020-06-03 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16.000 16.000
2020-06-05 2020-06-03 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 4,86 16.000 16.000
2020-02-14 2020-02-12 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 5,19 20.000 20.000
2020-02-14 2020-02-12 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 5,19 55.000 55.000
2020-02-14 2020-02-12 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 5,19 55.000 55.000
2020-02-14 2020-02-12 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 5,19 100.000 100.000
2020-02-14 2020-02-12 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 5,19 55.000 55.000
2020-02-14 2020-02-12 4 Sapir Alex PHAS Employee Stock Option (right to buy) A - Award D 5,19 32.000 32.000
2020-02-14 2020-02-12 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 5,19 100.000 100.000
2020-02-14 2020-02-12 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 5,19 55.000 55.000
2020-02-14 2020-02-12 4 Ballance David James PHAS Employee Stock Option (right to buy) A - Award D 5,19 55.000 55.000
2020-02-14 2020-02-12 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 5,19 290.000 290.000
2019-10-07 2019-10-07 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 4,17 66.000 66.000
2019-09-10 2019-09-06 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1,24 -19.000 158.767
2019-09-10 2019-09-06 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 19.000 24 109.243
2019-08-22 2019-08-21 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,44 -5.000 4.038
2019-08-22 2019-08-21 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,69 -10.000 110.582
2019-08-22 2019-08-21 4 Sharp John P PHAS Common Stock M - Exercise D 1,4400 5.000 7 35.000
2019-08-22 2019-08-21 4 Sharp John P PHAS Common Stock M - Exercise D 1,6900 10.000 17 30.000
2019-07-03 2019-07-01 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock S - Sale I 14,0000 -459 -6 415.959
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock S - Sale I 14,0000 -255 -4 52.397
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock S - Sale I 14,0000 -180 -3 162.890
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock S - Sale I 14,0000 -2.014 -28 1.818.638
2019-06-20 2019-06-18 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock S - Sale I 14,0000 -63 -1 416.418
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock S - Sale I 14,0000 -35 -0 52.655
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock S - Sale I 14,0000 -25 -0 163.074
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock S - Sale I 14,0000 -277 -4 1.820.656
2019-05-24 2019-05-22 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1,69 -15.000 120.582
2019-05-24 2019-05-22 4 Sharp John P PHAS Common Stock M - Exercise D 1,6900 15.000 25 20.000
2019-05-21 2019-05-20 4 Mow Jonathan P PHAS Employee stock option (right to buy) M - Exercise D 1,24 -19.131 0
2019-05-21 2019-05-20 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1,2400 19.131 24 90.243
2019-05-21 2019-05-17 4 Mow Jonathan P PHAS Employee stock option (right to buy) M - Exercise D 2,27 -19.913 0
2019-05-21 2019-05-17 4 Mow Jonathan P PHAS Common Stock M - Exercise D 2,2700 19.913 45 71.112
2019-05-13 2019-05-09 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11.000 11.000
2019-05-13 2019-05-09 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11.000 11.000
2019-05-13 2019-05-09 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 9.167 9.167
2019-05-13 2019-05-09 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 4.583 4.583
2019-05-13 2019-05-09 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 2.750 2.750
2019-05-13 2019-05-09 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11.000 11.000
2019-05-13 2019-05-09 4 Mukhopadhyay Bibhash PHAS Non-employee Director Stock Option (right to buy) A - Award D 13,23 11.000 11.000
2019-03-01 2019-02-27 4 TUFTS LINDA PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 36.000 36.000
2019-03-01 2019-02-27 4 Ballance David James PHAS Employee Stock Option (right to buy) A - Award D 3,15 45.000 45.000
2019-03-01 2019-02-27 4 Hutson Nancy J PHAS Employee Stock Option (right to buy) A - Award D 3,15 8.900 8.900
2019-03-01 2019-02-27 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 36.000 36.000
2019-03-01 2019-02-27 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 3,15 100.000 100.000
2019-03-01 2019-02-27 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 8.900 8.900
2019-03-01 2019-02-27 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 3,15 100.000 100.000
2019-03-01 2019-02-27 4 Thorp Clay PHAS Employee Stock Option (right to buy) A - Award D 3,15 36.000 36.000
2019-03-01 2019-02-27 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 23.000 23.000
2019-03-01 2019-02-27 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 22.000 22.000
2019-03-01 2019-02-27 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 3,15 45.000 45.000
2019-03-01 2019-02-27 4 Mukhopadhyay Bibhash PHAS Non-employee Director Stock Option (right to buy) A - Award D 3,15 36.000 36.000
2019-03-01 2019-02-27 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 3,15 263.000 263.000
2019-03-01 2019-02-27 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 3,15 45.000 45.000
2018-12-17 3/A Ballance David James PHAS Common Stock D 6.600
2018-12-17 2018-12-17 4 Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person PHAS Common Stock P - Purchase I 4,4600 1.000 4 1.000
2018-12-17 2018-12-13 4 Ballance David James PHAS Common Stock P - Purchase D 3,9400 1.000 4 7.600
2018-12-17 2018-12-13 4 HARRIGAN EDMUND PHAS Employee Stock Option (right to buy) A - Award D 3,65 68.966 68.966
2018-12-17 2018-12-13 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,6900 1.000 4 51.199
2018-12-13 2018-12-10 4/A Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8500 800 3 50.199
2018-12-13 2018-12-07 4/A Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8900 700 3 49.399
2018-12-11 2018-12-10 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8500 800 3 51.699
2018-12-11 2018-12-07 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3,8800 2.200 9 50.899
2018-12-11 2018-12-07 4 Sharp John P PHAS Common Stock P - Purchase D 3,8400 5.000 19 5.000
2018-12-11 2018-12-11 4 York Michael PHAS Common Stock P - Purchase D 3,8800 1.500 6 1.500
2018-12-06 2018-12-04 4 Thorp Clay PHAS Common Stock P - Purchase D 3,1300 4.000 13 15.799
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series D Preferred Stock C - Conversion I -1.124.301 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock C - Conversion I -437.706 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -4.349 -22 437.706
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock X - Other I 0,1200 181.190 22 442.055
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 -181.190 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock C - Conversion I -3.279.627 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock S - Sale I 5,0000 -1.177 -6 3.279.627
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock X - Other I 0,1200 49.030 6 3.280.804
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0,12 -49.030 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Common Stock P - Purchase I 5,0000 1.800.000 9.000 6.641.634
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Common Stock C - Conversion I 4.841.634 4.841.634
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock C - Conversion D -2.303 0
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock S - Sale D 5,0000 -3 -0 2.303
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock X - Other D 0,1200 103 0 2.306
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Warrants to Purchase Series B Preferred Stock X - Other D 0,12 -103 0
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Common Stock C - Conversion D 2.303 2.303
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Series B Preferred Stock C - Conversion D -2.306 0
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Series B Preferred Stock M - Exercise D 0,1200 103 0 2.306
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Warrants to Purchase Series B Preferred Stock M - Exercise D 0,12 -103 0
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Common Stock C - Conversion D 2.306 2.306
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series D Preferred Stock C - Conversion I -740.337 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock C - Conversion I -1.664.217 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -2.734 -14 1.664.217
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock X - Other I 0,1200 113.891 14 1.666.951
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 -113.891 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Common Stock P - Purchase I 5,0000 600.000 3.000 3.004.554
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Common Stock C - Conversion I 2.404.554 2.404.554
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series D Preferred Stock C - Conversion I -226.061 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series D Preferred Stock C - Conversion I -24.709 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series D Preferred Stock C - Conversion I -272.107 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock C - Conversion I -40.420 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock C - Conversion I -13.558 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock C - Conversion I -149.320 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock C - Conversion I -94.874 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock C - Conversion I -1.044.764 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series AA Preferred Stock C - Conversion I -13.609 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series AA Preferred Stock C - Conversion I -174.699 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC PHAS Series 1 Preferred Stock C - Conversion I -4.846 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series 1 Preferred Stock C - Conversion I -3.862 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series 1 Preferred Stock C - Conversion I -42.530 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP PHAS Series 1 Preferred Stock C - Conversion I -52.690 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -994 -5 40.420
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock X - Other I 0,1200 41.414 5 41.414
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 -41.414 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -104 -1 13.558
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock X - Other I 0,1200 4.309 1 13.662
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 -4.309 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -1.139 -6 149.320
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock X - Other I 0,1200 47.458 6 150.459
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0,12 -47.458 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -42 -0 94.874
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock X - Other I 0,1200 1.731 0 94.916
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0,12 -1.731 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -458 -2 1.044.764
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock X - Other I 0,1200 19.061 2 1.045.222
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0,12 -19.061 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Common Stock P - Purchase I 5,0000 150.000 750 416.481
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Common Stock C - Conversion I 266.481 266.481
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC PHAS Common Stock C - Conversion I 4.846 4.846
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Common Stock P - Purchase I 5,0000 12.487 62 163.099
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Common Stock C - Conversion I 150.612 150.612
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Common Stock P - Purchase I 5,0000 137.513 688 1.820.933
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Common Stock C - Conversion I 1.683.420 1.683.420
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP PHAS Common Stock C - Conversion I 52.690 52.690
2018-10-24 2018-10-22 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Series B Preferred Stock C - Conversion I -3.505 0
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Series B Preferred Stock C - Conversion D -310 0
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Series B Preferred Stock M - Exercise D 0,1200 310 0 310
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Warrants to Purchase Series B Preferred Stock M - Exercise D 0,12 -310 0
2018-10-24 2018-10-22 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock C - Conversion I 3.505 48.699
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Common Stock C - Conversion D 310 310
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series D Preferred Stock C - Conversion I -226.061 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series D Preferred Stock C - Conversion I -24.709 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series D Preferred Stock C - Conversion I -272.107 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock C - Conversion I -40.420 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock C - Conversion I -13.558 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock C - Conversion I -149.320 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock C - Conversion I -94.874 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock C - Conversion I -1.044.764 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series AA Preferred Stock C - Conversion I -13.609 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series AA Preferred Stock C - Conversion I -174.699 0
2018-10-24 2018-10-22 4 Thorp Clay By Catalysta Ventures, LLC PHAS Series 1 Preferred Stock C - Conversion I -4.846 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series 1 Preferred Stock C - Conversion I -3.862 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series 1 Preferred Stock C - Conversion I -42.530 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Series 1 Preferred Stock C - Conversion I -52.690 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -994 -5 40.420
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 41.414 5 41.414
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -41.414 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -104 -1 13.558
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 4.309 1 13.662
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -4.309 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -1.139 -6 149.320
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 47.458 6 150.459
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -47.458 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -42 -0 94.874
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 1.731 0 94.916
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 -1.731 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -458 -2 1.044.764
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 19.061 2 1.045.222
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 -19.061 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock P - Purchase I 5,0000 150.000 750 416.481
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock C - Conversion I 266.481 266.481
2018-10-24 2018-10-22 4 Thorp Clay By Catalysta Ventures, LLC PHAS Common Stock C - Conversion I 4.846 4.846
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock P - Purchase I 5,0000 12.487 62 163.099
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock C - Conversion I 150.612 150.612
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock P - Purchase I 5,0000 137.513 688 1.820.933
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock C - Conversion I 1.683.420 1.683.420
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock C - Conversion I 52.690 52.690
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series D Preferred Stock C - Conversion I -30.334 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series D Preferred Stock C - Conversion I -6.413 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series D Preferred Stock C - Conversion I -63.688 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock C - Conversion I -22.452 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock C - Conversion I -4.746 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock C - Conversion I -47.140 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock C - Conversion I -165.395 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock C - Conversion I -34.968 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock C - Conversion I -347.250 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series AA Preferred Stock C - Conversion I -56.874 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series AA Preferred Stock C - Conversion I -12.025 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series AA Preferred Stock C - Conversion I -119.408 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -113 -1 22.452
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 4.690 1 22.565
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -4.690 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -24 -0 4.746
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 991 0 4.770
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -991 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock S - Sale I 5,0000 -237 -1 47.140
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock M - Exercise I 0,1200 9.847 1 47.377
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0,12 -9.847 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -81 -0 165.395
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 3.359 0 165.476
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 -3.359 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -18 -0 34.968
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 710 0 34.986
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 -710 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock S - Sale I 5,0000 -170 -1 347.250
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock M - Exercise I 0,1200 7.053 1 347.420
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0,12 -7.053 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Common Stock P - Purchase I 5,0000 6.041 30 281.096
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Common Stock C - Conversion I 275.055 275.055
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Common Stock P - Purchase I 5,0000 1.277 6 59.429
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Common Stock C - Conversion I 58.152 58.152
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Common Stock P - Purchase I 5,0000 12.682 63 590.168
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Common Stock C - Conversion I 577.486 577.486
2018-10-17 2018-10-17 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 5,00 220.000 220.000
2018-10-17 3 Thorp Clay PHAS Common Stock D 23.598
2018-10-17 3 Thorp Clay PHAS Common Stock D 23.598
2018-10-17 3 Thorp Clay PHAS Common Stock D 23.598
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90.388
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90.388
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90.388
P
Piața deschisă sau achiziția privată de titluri nederivate sau derivate
S
Piața deschisă sau vânzarea privată a titlurilor de valoare nederivate sau derivate
A
Acordarea, atribuirea sau alte achiziții de valori mobiliare de la companie (cum ar fi o opțiune)
C
Conversia derivatei
D
Vânzarea sau transferul de valori mobiliare înapoi către companie
F
Plata prețului de exercițiu sau a obligației fiscale folosind o parte din titlurile de valoare primite de la companie
G
Donarea de valori mobiliare de către sau către persoane din interior
K
Swap-uri de acțiuni și tranzacții similare de acoperire împotriva riscurilor
M
Exercitarea sau conversia titlurilor derivate primite de la companie (cum ar fi o opțiune)
V
O tranzacție raportată voluntar pe Formularul 4
J
Altele (însoțite de o notă de subsol care descrie tranzacția)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista